SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-12.27%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$254M
AUM Growth
+$254M
(+2.3%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
9.08%
Top 10 Holdings %
Top 10 Hldgs %
57%
Holding
82
New
16
Increased
14
Reduced
8
Closed
18
Top Buys
| 1 |
Organon & Co
OGN
|
$19.4M |
| 2 |
Cencora
COR
|
$14.2M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$10.7M |
| 4 |
HCA Healthcare
HCA
|
$10.4M |
| 5 |
Biogen
BIIB
|
$7.32M |
Top Sells
| 1 |
Merck
MRK
|
$16M |
| 2 |
Sanofi
SNY
|
$15.4M |
| 3 |
Labcorp
LH
|
$13M |
| 4 |
McKesson
MCK
|
$10.6M |
| 5 |
Galapagos
GLPG
|
$9.1M |
Sector Composition
| 1 | Healthcare | 88.2% |
| 2 | Financials | 8.95% |
| 3 | Consumer Staples | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cencora
COR
$56.5B
| $25.9M | 9.74% | 183,334 +100,063 | +120% | +$14.2M |
|
|
MSAC
2
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $22.7M | 8.53% | 2,323,000 | – | – |
|
|
3
Organon & Co
OGN
$2.45B
| $19.4M | 7.29% | +574,855 | New | +$19.4M |
|
4
Cigna
CI
$80.3B
| $14M | 5.25% | 53,034 -14,796 | -22% | -$3.9M |
|
5
Inogen
INGN
$216M
| $12.7M | 4.77% | 525,438 +125,352 | +31% | +$3.03M |
|
|
BCYC
6
Bicycle Therapeutics
BCYC
$511M
| $11.6M | 4.34% | 688,989 +636,201 | +1,205% | +$10.7M |
|
7
Centene
CNC
$14.3B
| $10.9M | 4.1% | 129,011 +32,249 | +33% | +$2.73M |
|
|
8
HCA Healthcare
HCA
$94.5B
| $10.4M | 3.91% | +61,953 | New | +$10.4M |
|
9
United Therapeutics
UTHR
$13.8B
| $9.42M | 3.54% | 39,959 -15,303 | -28% | -$3.61M |
|
|
NARI
10
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.65M | 2.87% | 112,466 +72,256 | +180% | +$4.91M |
|
|
11
Biogen
BIIB
$19.4B
| $7.32M | 2.75% | +35,900 | New | +$7.32M |
|
12
Medtronic
MDT
$119B
| $7.18M | 2.7% | +80,000 | New | +$7.18M |
|
13
Sight Sciences
SGHT
$213M
| $6.52M | 2.45% | +724,944 | New | +$6.52M |
|
|
NTUS
14
DELISTED
Natus Medical Inc
NTUS
| $6.26M | 2.35% | 190,956 -608 | -0.3% | -$19.9K |
|
15
Cardinal Health
CAH
$35.5B
| $6.22M | 2.34% | +119,061 | New | +$6.22M |
|
16
Tenet Healthcare
THC
$16.3B
| $5.52M | 2.07% | +105,000 | New | +$5.52M |
|
17
Vanda Pharmaceuticals
VNDA
$279M
| $5.33M | 2% | 488,965 +326,487 | +201% | +$3.56M |
|
|
BHVN
18
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.1M | 1.92% | +35,000 | New | +$5.1M |
|
19
The Beauty Health Co
SKIN
$264M
| $4.66M | 1.75% | +362,294 | New | +$4.66M |
|
|
INBX
20
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4.15M | 1.56% | 365,210 +240,960 | +194% | +$2.73M |
|
21
Universal Health Services
UHS
$11.6B
| $4.1M | 1.54% | +40,725 | New | +$4.1M |
|
|
HSKA
22
DELISTED
Heska Corp
HSKA
| $3.74M | 1.4% | +39,566 | New | +$3.74M |
|
|
PNT
23
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.44M | 1.29% | 504,545 +126,861 | +34% | +$864K |
|
|
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.19M | 1.2% | +40,000 | New | +$3.19M |
|
25
Modular Medical
MODD
$39.9M
| $2.98M | 1.12% | +574,352 | New | +$2.98M |
|